A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Pegylated Liposomal Doxorubicin|DRUG: Docetaxel|DRUG: Trastuzumab
Sponsor: Merck Sharp & Dohme LLC
Collaborators: MDS Pharma Services